{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:30:47Z","timestamp":1787632247881,"version":"build-2736575974"},"reference-count":23,"publisher":"VM Media SP. zo.o VM Group SK","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","oncology-and-radiotherapy.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.rpor.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T21:36:09Z","timestamp":1588800969000},"page":"479-483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Should high-dose-rate brachytherapy boost be used in early nasopharyngeal carcinomas?"],"prefix":"10.5603","volume":"25","author":[{"given":"Jose Luis","family":"Guinot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Quiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Sanchez-Relucio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alonso","family":"La Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Tortajada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leoncio","family":"Arribas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3595","reference":[{"issue":"6","key":"10.1016\/j.rpor.2020.04.001_bib0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.canep.2013.08.008","article-title":"Racial differences in nasopharyngeal carcinoma in the United States","volume":"37","author":"Wang","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.rpor.2020.04.001_bib0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-8140(01)00448-0","article-title":"Nasopharyngeal carcinomas; analysis of patient, tumor and treatment characteristics determining outcome","volume":"61","author":"Erkal","year":"2001","journal-title":"Radiother Oncol"},{"issue":"26","key":"10.1016\/j.rpor.2020.04.001_bib0015","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa011610","article-title":"Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men","volume":"345","author":"Chien","year":"2001","journal-title":"New Eng J Medicine"},{"key":"10.1016\/j.rpor.2020.04.001_bib0020","first-page":"1","article-title":"Nasopharyngeal carcinoma","volume":"26","author":"Brennan","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.rpor.2020.04.001_bib0025","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0360-3016(92)90740-9","article-title":"Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure","volume":"23","author":"Lee","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.rpor.2020.04.001_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.06.037","article-title":"Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients","volume":"64","author":"Baujat","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.rpor.2020.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0360-3016(03)00117-2","article-title":"Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma","volume":"56","author":"Le","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2020.04.001_bib0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0360-3016(01)02719-5","article-title":"Role of endocavitary brachytherapy with or without chemotherapy in cancer of the nasopharynx","volume":"52","author":"Levendag","year":"2002","journal-title":"Int J Radiant Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2020.04.001_bib0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1538-4721(02)00013-2","article-title":"Managing nasopharyngeal carcinoma with intracavitary brachytherapy: one institution\u2019s 45-year experience","volume":"1","author":"Lee","year":"2002","journal-title":"Brachytherapy"},{"key":"10.1016\/j.rpor.2020.04.001_bib0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brachy.2012.06.001","article-title":"Local control in advanced cancer of the nasopharynx: is a boost dose by endocavitary brachytherapy of prognostic significance?","volume":"12","author":"Levendag","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.rpor.2020.04.001_bib0055","series-title":"Pharynx","first-page":"41","article-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2010"},{"issue":"October (4)","key":"10.1016\/j.rpor.2020.04.001_bib0060","article-title":"Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinoma","volume":"18","author":"Baujat","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"May (5)","key":"10.1016\/j.rpor.2020.04.001_bib0065","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hed.20161","article-title":"Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group","volume":"27","author":"Yu","year":"2005","journal-title":"Head Neck"},{"issue":"May (2)","key":"10.1016\/j.rpor.2020.04.001_bib0070","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0360-3016(98)00063-7","article-title":"Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment","volume":"41","author":"Chua","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.rpor.2020.04.001_bib0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-717X-9-67","article-title":"Brachytherapy boost in loco \u2013 regionally advanced nasopharyngeal carcinoma: a prospective randomized trial of the International Atomic Energy Agency","volume":"9","author":"Rosenblatt","year":"2014","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.rpor.2020.04.001_bib0080","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/jrr\/rrx034","article-title":"Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy","volume":"58","author":"Chao","year":"2017","journal-title":"J Radiat Res"},{"key":"10.1016\/j.rpor.2020.04.001_bib0085","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1186\/1471-2407-14-894","article-title":"3D-image-guided HDR-brachytherapy versus 2D HDR - brachytherapy after external beam radiotherapy for early T-stage nasopharyngeal carcinoma","volume":"14","author":"Ren","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.rpor.2020.04.001_bib0090","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0167-8140(97)00105-9","article-title":"A new applicator design for endocavitary brachytherapy of cancer in the nasopharynx","volume":"45","author":"Levendag","year":"1997","journal-title":"Radiother Oncol"},{"issue":"June (6)","key":"10.1016\/j.rpor.2020.04.001_bib0095","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.MLG.0000215173.14473.D0","article-title":"Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome","volume":"116","author":"Thiagarajan","year":"2006","journal-title":"Laryngoscope"},{"issue":"Febuary (2)","key":"10.1016\/j.rpor.2020.04.001_bib0100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2007.06.078","article-title":"High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma","volume":"70","author":"Leung","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.rpor.2020.04.001_bib0105","doi-asserted-by":"crossref","first-page":"6010","DOI":"10.1002\/cam4.1866","article-title":"Local regression and control of T1-2 nasopharyngeal carcinoma treated with Intensity \u2013Modulated Radiotherapy","volume":"7","author":"Xue","year":"2018","journal-title":"Cancer Med."},{"issue":"December (5)","key":"10.1016\/j.rpor.2020.04.001_bib0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0360-3016(96)00416-6","article-title":"The role of brachytherapy in early-stage nasopharyngeal carcinoma","volume":"36","author":"Chang","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.rpor.2020.04.001_bib0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.radonc.2016.10.008","article-title":"GEC-ESTRO ACROP recommendations for head & neck brachytherapy in squamous cell carcinomas: 1st update \u2013 Improvement by cross sectional imaging based treatment planning and stepping source technology","volume":"122","author":"Kovacs","year":"2017","journal-title":"Radiother Oncol"}],"container-title":["Reports of Practical Oncology &amp; Radiotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720300547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1507136720300547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T14:15:51Z","timestamp":1613657751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1507136720300547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1507136720300547"],"URL":"https:\/\/doi.org\/10.1016\/j.rpor.2020.04.001","relation":{},"ISSN":["1507-1367"],"issn-type":[{"value":"1507-1367","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should high-dose-rate brachytherapy boost be used in early nasopharyngeal carcinomas?","name":"articletitle","label":"Article Title"},{"value":"Reports of Practical Oncology & Radiotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpor.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}